Unaudited Interim Consolidated Statement of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net sales	$ 1,460	$ 1,687
Cost of sales	(1,112)	(1,234)
Gross profit	348	453
Selling, general and administrative expenses	(125)	(120)
Amortization of intangible assets	(5)	(6)
Research and development expenses	(17)	(16)
Other (charges) gains, net	(6)	4
Foreign exchange gain (loss), net	(1)	5
Gain (loss) on disposition of businesses and assets, net	0	0
Operating profit (loss)	194	320
Equity in net earnings (loss) of affiliates	57	50
Non-operating pension and other postretirement employee benefit (expense) income	28	17
Interest expense	(28)	(31)
Interest income	2	1
Dividend income - equity investments	37	32
Other income (expense), net	2	(4)
Earnings (loss) from continuing operations before tax	292	385
Income tax (provision) benefit	(65)	(46)
Earnings (loss) from continuing operations	227	339
Earnings (loss) from operation of discontinued operations	(7)	(1)
Income tax (provision) benefit from discontinued operations	0	0
Earnings (loss) from discontinued operations	(7)	(1)
Net earnings (loss)	220	338
Net (earnings) loss attributable to noncontrolling interests	(2)	(1)
Net earnings (loss) attributable to Celanese Corporation	218	337
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	225	338
Earnings (loss) from discontinued operations	(7)	(1)
Net earnings (loss)	$ 218	$ 337
Earnings (loss) per common share - basic
Continuing operations	$ 1.89	$ 2.65
Discontinued operations	(0.06)	(0.01)
Net earnings (loss) - basic	1.83	2.64
Earnings (loss) per common share - diluted
Continuing operations	1.88	2.64
Discontinued operations	(0.06)	(0.01)
Net earnings (loss) - diluted	$ 1.82	$ 2.63
Weighted average shares - basic	119,251,689	127,542,328
Weighted average shares - diluted	119,899,844	128,215,700